FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to cardiovascular surgery, can be used in clinical practice in correction of acquired heart diseases for prediction of risk of developing abdominal complications. Patient is examined. It is followed by postinfarction cardiosclerosis, resternotomy, acute cardiovascular insufficiency, duration of artificial blood circulation during operation. If using extracorporeal membrane oxygenation in the postoperative period, 4 points are assigned. If observing postinfarction cardiosclerosis – 1 point. When carrying out the coronary bypass disease, 1 point is assigned. If developing acute cardiovascular insufficiency – 1 point. Duration of the artificial blood circulation during the operation is more than 125 minutes – 1 point, the risk of developing abdominal complications by the total score is determined. At same time 0 points corresponds to low risk with probability of development – 0.1 %; 1–2 points – moderate risk with probability of 1.8 %; 3 points – high risk with probability of 4.2 %; 4 and more points – very high with probability - 12.5 %.
EFFECT: method enables providing an individual prediction of the development of early abdominal complications after correction of acquired heart diseases in conditions of artificial blood circulation by detecting and assessing risk factors with assignment of certain points reflecting degree of their contribution to the final risk.
1 cl, 5 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF RISK OF DEVELOPING EARLY ABDOMINAL COMPLICATIONS IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS SURGERY IN CARDIOPULMONARY BYPASS | 2018 |
|
RU2692455C1 |
METHOD FOR PREDICTION OF RISK OF MULTIPLE ORGAN FAILURE SYNDROME DEVELOPMENT IN PATIENTS AFTER HEART BYPASS | 2017 |
|
RU2641033C1 |
METHOD OF PREDICTING RISK OF DEVELOPING POLYORGAN INSUFFICIENCY IN CARDIO-SURGICAL PATIENTS | 2010 |
|
RU2422092C1 |
METHOD FOR PREDICTING THE NEED FOR ALLOGENEIC ERYTHROCYTE-CONTAINING BLOOD COMPONENTS IN PLANNED CARDIOSURGICAL INTERVENTIONS IN ADULT PATIENTS IN INTRAOPERATIVE AND EARLY POSTOPERATIVE PERIODS | 2017 |
|
RU2657771C1 |
METHOD OF PREDICTING THE RISK OF DEVELOPMENT OF COMPLICATIONS IN THE EARLY HOSPITAL PERIOD OF PATIENTS AFTER CORONARY SHUNTING IN THE CONDITIONS OF ARTIFICIAL CIRCULATION | 2017 |
|
RU2642238C1 |
METHOD FOR PREDICTION OF DEVELOPING COMPLICATED SYSTEMIC INFLAMMATION RESPONSE IN PATIENTS WITH SEPTIC ENDOCARDITIS | 2013 |
|
RU2520753C1 |
METHOD OF PREDICTING ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ETIOLOGY WITHIN A YEAR AFTER CORONARY ARTERY BYPASS GRAFTING | 2022 |
|
RU2801160C1 |
METHOD FOR FORECASTING THE NEED FOR THE ALLOGENIC ERYTHROCY-CONTAINING COMPONENTS OF BLOOD IN THE INTRAOPERATIVE AND EARLY POSTOPERATIVE PERIODS IN CORONARY BYPASS SURGERY | 2017 |
|
RU2660707C1 |
METHOD FOR PREDICTION OF SEPSIS FOLLOWING CARDIOSURGICAL OPERATIONS PERFORMED IN CONDITIONS OF ARTIFICIAL BLOOD CIRCULATION | 2019 |
|
RU2713930C1 |
METHOD FOR PREDICTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE IN A COMBINATION WITH POSTINFARCTION LEFT VENTRICULAR ANEURYSM | 2019 |
|
RU2712629C1 |
Authors
Dates
2020-10-12—Published
2020-01-20—Filed